Firm intentionHealthcare28 July 2026

Scott Livingston to acquire Mindflair plc

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Scott Livingston
Target
Mindflair plc
Deal value
GBP 193,409
Announced
28 July 2026
Status
Firm intention
Sector
Healthcare
Country
Not stated
Consideration
cash
What we know

Scott Livingston has agreed to acquire the assets of Mindflair plc in a cash transaction valued at 193,409 GBP. The deal, announced on 28 July 2026, involves the purchase of specific business assets rather than a full equity takeover. This structure is classified as an asset sale within the healthcare sector. The consideration is provided entirely in cash, with no shares or other instruments involved in the exchange. The headline offer figure represents the total value agreed upon by both parties for the acquisition of these assets.

The transaction is currently at the firm intention stage. Both parties have expressed a clear commitment to proceed with the deal, but it has not yet been completed. The completion date remains unreported and is subject to further developments. Regulatory approvals or other conditions may need to be satisfied before the transfer of assets can be finalised. This stage indicates that the deal is progressing but is not yet legally closed. The focus remains on the successful transfer of the healthcare assets from Mindflair plc to Scott Livingston under the agreed terms.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. Firm intention

    Disposal of non-core shareholding in Mindflair plc

    Disclaimer* 28 July 2026     Tooru plc ("Tooru" or the "Company")   Disposal of non-core shareholding in Mindflair plc   Tooru, the AIM listed company focused on the branded health and wellness sector, announces that it has agreed to sell its entire shareholding of 42,979,737 shares in Mindflair plc ("Mindflair") to the Company's CEO, Scott Livingston, at a price of 0.45

    LSE RNS

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Scott Livingston

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive